GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jenscare Scientific Co Ltd (HKSE:09877) » Definitions » Loans Receivable

Jenscare Scientific Co (HKSE:09877) Loans Receivable : HK$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Jenscare Scientific Co Loans Receivable?

Jenscare Scientific Co's Loans Receivable for the quarter that ended in Jun. 2024 was HK$0.00 Mil.


Jenscare Scientific Co Loans Receivable Historical Data

The historical data trend for Jenscare Scientific Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jenscare Scientific Co Loans Receivable Chart

Jenscare Scientific Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
- - - - -

Jenscare Scientific Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only - - - - -

Jenscare Scientific Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Jenscare Scientific Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of Jenscare Scientific Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Jenscare Scientific Co Business Description

Traded in Other Exchanges
N/A
Address
No. 777 Binhai 4th Road, Block 5, B Area, Hangzhou Bay New Area, Zhejiang Province, Ningbo, CHN
Jenscare Scientific Co Ltd is a China-based company mainly engaged in the manufacturing and research and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure.
Executives
Li Hui 2501 Other
Trident Trust Company (hk) Limited 2301 Trustee
Trinity Elite I International Limited 2201 Interest of corporation controlled by you
Lv Shiwen 2501 Other
Ningbo Dixiang Venture Capital Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Shidi Industrial Development Co., Ltd. 2501 Other
Pan Fei 2201 Interest of corporation controlled by you
Shanghai Jiachen Investment Co.,ltd 2201 Interest of corporation controlled by you
Ningbo Sangdi Investment Management L.p. (limited Partnership) 2101 Beneficial owner
Ningbo Linfeng Biotechnology Co., Ltd. 2101 Beneficial owner
Hainan Yize Medical Technology Co., Limited 2201 Interest of corporation controlled by you
Hainan Maidi Enterprise Management L.p. (limited Partnership) 2101 Beneficial owner
Hainan Hualing Investment L.p. (limited Partnership) 2101 Beneficial owner
Hangzhou Chende Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Mukang Venture Capital Partnership (limited Partnership)

Jenscare Scientific Co Headlines

No Headlines